Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism

Polyphenol curcumin, a yellow pigment, derived from the rhizomes of a plant (Curcuma longa Linn) is a natural antioxidant exhibiting a variety of pharmacological activities and therapeutic properties. It has long been used as a traditional medicine and as a preservative and coloring agent in foods. Here, curcumin-converting microorganisms were isolated from human feces, the one exhibiting the highest activity being identified as Escherichia coli. We are thus unique in discovering that E. coli was able to act on curcumin. The curcumin-converting enzyme was purified from E. coli and characterized. The native enzyme had a molecular mass of about 82 kDa and consisted of two identical subunits. The enzyme has a narrow substrate spectrum, preferentially acting on curcumin. The microbial metabolism of curcumin by the purified enzyme was found to comprise a two-step reduction, curcumin being converted NADPH-dependently into an intermediate product, dihydrocurcumin, and then the end product, tetrahydrocurcumin. We named this enzyme “NADPH-dependent curcumin/dihydrocurcumin reductase” (CurA). The gene (curA) encoding this enzyme was also identified. A homology search with the BLAST program revealed that a unique enzyme involved in curcumin metabolism belongs to the medium-chain dehydrogenase/reductase superfamily.

[1]  Nicola K. Petty,et al.  A Commensal Gone Bad: Complete Genome Sequence of the Prototypical Enterotoxigenic Escherichia coli Strain H10407 , 2010, Journal of bacteriology.

[2]  S. d'Auria,et al.  Properties and evolution of an alcohol dehydrogenase from the Crenarchaeota Pyrobaculum aerophilum. , 2010, Gene.

[3]  L. Beutin,et al.  Derivation of Escherichia coli O157:H7 from Its O55:H7 Precursor , 2010, PloS one.

[4]  Lei Wang,et al.  Genomic Sequencing Reveals Regulatory Mutations and Recombinational Events in the Widely Used MC4100 Lineage of Escherichia coli K-12 , 2009, Journal of bacteriology.

[5]  B. Persson,et al.  Medium- and short-chain dehydrogenase/reductase gene and protein families , 2008, Cellular and Molecular Life Sciences.

[6]  Takashi Morihara,et al.  Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer's Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.

[7]  S. Garbisa,et al.  Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA , 2008, Acta Pharmacologica Sinica.

[8]  R. Planalp,et al.  Curcumin: From ancient medicine to current clinical trials , 2008, Cellular and Molecular Life Sciences.

[9]  Schuyler F. Baldwin,et al.  The Complete Genome Sequence of Escherichia coli DH10B: Insights into the Biology of a Laboratory Workhorse , 2008, Journal of bacteriology.

[10]  B. Hyman,et al.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model , 2007, Journal of neurochemistry.

[11]  L. Pari,et al.  Antihyperlipidemic Effect of Curcumin and Tetrahydrocurcumin in Experimental Type 2 Diabetic Rats , 2007, Renal failure.

[12]  D. Bedgar,et al.  Mechanistic and Structural Studies of Apoform, Binary, and Ternary Complexes of the Arabidopsis Alkenal Double Bond Reductase At5g16970* , 2006, Journal of Biological Chemistry.

[13]  M. Panchatcharam,et al.  Curcumin improves wound healing by modulating collagen and decreasing reactive oxygen species , 2006, Molecular and Cellular Biochemistry.

[14]  P. Rangarajan,et al.  Curcumin-Artemisinin Combination Therapy for Malaria , 2006, Antimicrobial Agents and Chemotherapy.

[15]  M. Metzler,et al.  Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. , 2006, Journal of agricultural and food chemistry.

[16]  Ricky A. Sharma,et al.  Curcumin: the story so far. , 2005, European journal of cancer.

[17]  T. Kensler,et al.  The Catalytic and Kinetic Mechanisms of NADPH-dependent Alkenal/one Oxidoreductase* , 2004, Journal of Biological Chemistry.

[18]  Tetsuya Hori,et al.  Structural Basis of Leukotriene B4 12-Hydroxydehydrogenase/15-Oxo-prostaglandin 13-Reductase Catalytic Mechanism and a Possible Src Homology 3 Domain Binding Loop* , 2004, Journal of Biological Chemistry.

[19]  B. Persson,et al.  Medium‐chain dehydrogenases/reductases (MDR) , 2002 .

[20]  A. Párraga,et al.  Structure of human biliverdin IXβ reductase, an early fetal bilirubin IXβ producing enzyme , 2001, Nature Structural Biology.

[21]  L. Howells,et al.  Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. , 2001, Cancer research.

[22]  S. DeKosky,et al.  Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. , 2000, Archives of neurology.

[23]  Jen-kun Lin,et al.  Biotransformation of curcumin through reduction and glucuronidation in mice. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[24]  B. Persson,et al.  SDR and MDR: completed genome sequences show these protein families to be large, of old origin, and of complex nature , 1999, FEBS letters.

[25]  U. Muthane,et al.  Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India , 1998, Annals of neurology.

[26]  T. Osawa,et al.  Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. , 1996, Biochemical pharmacology.

[27]  L. S. Steijns,et al.  [Apolipoprotein E polymorphism and Alzheimer disease]. , 1996, Tijdschrift voor gerontologie en geriatrie.

[28]  T. Osawa,et al.  Antioxidative activity of tetrahydrocurcuminoids. , 1995, Bioscience, biotechnology, and biochemistry.

[29]  N. Ghatak,et al.  Anti-inflammatory and irritant activities of curcumin analogues in rats , 1982, Agents and Actions.

[30]  E. H. Strickland.  Circular dichroism of horseradish peroxidase and its enzyme-substrate compounds. , 1968, Biochimica et biophysica acta.

[31]  L. Max.  Differentiation of B. Coli and B. Aerogens on a Simplified Eosin-Methylene Blue Agar , 1918 .

[32]  A. Macconkey,et al.  Lactose-Fermenting Bacteria in Faeces , 1905, Journal of Hygiene.

[33]  S. Nakornchai,et al.  Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. , 2007, Biological & pharmaceutical bulletin.

[34]  B. Aggarwal,et al.  Curcumin: the Indian solid gold. , 2007, Advances in experimental medicine and biology.

[35]  B. Persson,et al.  Medium-chain dehydrogenases/reductases (MDR). Family characterizations including genome comparisons and active site modeling. , 2002, European journal of biochemistry.

[36]  Donald J L Jones,et al.  Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  A. Párraga,et al.  Structure of human biliverdin IXbeta reductase, an early fetal bilirubin IXbeta producing enzyme. , 2001, Nature structural biology.

[38]  V. Ravindranath,et al.  In vitro studies on the intestinal absorption of curcumin in rats. , 1981, Toxicology.

[39]  H. Britton,et al.  CXCVIII.—Universal buffer solutions and the dissociation constant of veronal , 1931 .